Mingchen Lv
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mingchen Lv has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Jianzhong Du
East China University of Science and Technology
9 shared publications - Zhen Fan
Tongji University 4800 Caoan Road
9 shared publications - Min Sun
East China University of Science and Technology
8 shared publications - Jiaxi Xu
Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China
2 shared publications - Jinlong Qin
Department of Obstetrics and Gynecology, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, China
2 shared publications - Ran Chen
Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China
2 shared publications
Latest Publications
- Open Access
- 28 August 2025
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 5 (9) , 4346-4360
A Metal-Peptide Framework as a Nanozyme for the Attenuation of Amyloid-β Aggregation and Reactive Oxygen Species
Alzheimer’s disease (AD) is an irreversible neurodegenerative disease characterized by abnormal performance in memory, cognition, and language, and it imposes a heavy economic burden worldwide. Amyloidosis and oxidative stress are highly associated with AD progression, yet limited clinical drugs are available at present. Nanozymes exhibit diverse enzyme-mimetic activities and have attracted widespread attention as a promising alternative candidate for scavenging reactive oxygen species to maintain the oxidation–antioxidation balance in cells. Neurotoxic amyloid-β (Aβ) aggregation is also a critical event in AD pathology. The development of dual-targeting nanomaterials with antiamyloidosis ability and enzyme-mimicking activity is expected to be a promising strategy for the treatment of amyloidosis and reactive oxygen species-mediated AD progression. Here, bimetallic-peptide framework nanozymes (CuZn-PEP NZs) with amyloid-β (Aβ) attenuating ability, multiple enzyme-mimicking properties, and broad-spectrum reactive oxygen species scavenging capacity were endowed to inhibit Aβ fibrillization, disaggregate Aβ fibrils, and scavenge Aβ fibril-induced reactive oxygen species. An obvious inhibitory effect on Aβ fibrillization and a disaggregation effect on Aβ fibrils were observed after treatment with CuZn-PEP NZs. Meanwhile, the cytotoxicity of Aβ fibrils toward PC12 cells was significantly reduced by CuZn-PEP NZs. Meanwhile, CuZn-PEP NZs with multiple redox pairs exhibit superoxide dismutase, catalase, and glutathione peroxidase-mimicking enzyme properties simultaneously, which further display cytoprotective effects against Aβ fibril-induced reactive oxygen species and mitochondrial damage. Besides, cellular studies verified that CuZn-PEP NZs possess excellent biocompatibility and blood–brain barrier penetration capacity. Overall, these bimetallic-peptide framework nanozymes represent a promising perspective for attenuation of amyloid-β aggregation and reactive oxygen species simultaneously, which highlights the potential of nanozymes for the treatment of amyloidosis and reactive oxygen species-mediated AD progression.
- 28 August 2025
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 5 (9) , 4346-4360
Open AccessA Metal-Peptide Framework as a Nanozyme for the Attenuation of Amyloid-β Aggregation and Reactive Oxygen Species
Alzheimer’s disease (AD) is an irreversible neurodegenerative disease characterized by abnormal performance in memory, cognition, and language, and it imposes a heavy economic burden worldwide. Amyloidosis and oxidative stress are highly associated with AD progression, yet limited clinical drugs are available at present. Nanozymes exhibit diverse enzyme-mimetic activities and have attracted widespread attention as a promising alternative candidate for scavenging reactive oxygen species to maintain the oxidation–antioxidation balance in cells. Neurotoxic amyloid-β (Aβ) aggregation is also a critical event in AD pathology. The development of dual-targeting nanomaterials with antiamyloidosis ability and enzyme-mimicking activity is expected to be a promising strategy for the treatment of amyloidosis and reactive oxygen species-mediated AD progression. Here, bimetallic-peptide framework nanozymes (CuZn-PEP NZs) with amyloid-β (Aβ) attenuating ability, multiple enzyme-mimicking properties, and broad-spectrum reactive oxygen species scavenging capacity were endowed to inhibit Aβ fibrillization, disaggregate Aβ fibrils, and scavenge Aβ fibril-induced reactive oxygen species. An obvious inhibitory effect on Aβ fibrillization and a disaggregation effect on Aβ fibrils were observed after treatment with CuZn-PEP NZs. Meanwhile, the cytotoxicity of Aβ fibrils toward PC12 cells was significantly reduced by CuZn-PEP NZs. Meanwhile, CuZn-PEP NZs with multiple redox pairs exhibit superoxide dismutase, catalase, and glutathione peroxidase-mimicking enzyme properties simultaneously, which further display cytoprotective effects against Aβ fibril-induced reactive oxygen species and mitochondrial damage. Besides, cellular studies verified that CuZn-PEP NZs possess excellent biocompatibility and blood–brain barrier penetration capacity. Overall, these bimetallic-peptide framework nanozymes represent a promising perspective for attenuation of amyloid-β aggregation and reactive oxygen species simultaneously, which highlights the potential of nanozymes for the treatment of amyloidosis and reactive oxygen species-mediated AD progression.
- 14 August 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (34) , 48017-48028
Ultrasound-Driven Cu-Nanobots for Tumor Deep Penetration and Induction of Cuproptosis in Prostate Cancer Therapy
Cuproptosis has attracted considerable attention in cancer therapy due to its unique ability to circumvent drug resistance, while the in vivo application is hindered by systemic toxicity, rapid clearance, and limited tumor tissue penetration. Widely recognized for its noninvasive application, ultrasound has emerged as a promising method for enhancing drug tumor penetration. In this study, we developed cuproptosis-oriented Nanobots to achieve deep penetration into prostate tumors under ultrasound irradiation. Asymmetric Cu-Nanobots (∼200 nm) were prepared by ultrasound polymerization using hexachlorocyclotriphosphonitrile (HCCP), 4,4'-sulfonyldiphenol (BPS), and tannic acid (TA) as raw materials, which can efficiently load Cu2+ and trigger Cu2+ release at acidic tumor microenvironments. Under ultrasound stimulation, Cu-Nanobots showed obvious directional motion with a velocity of 19.49 μm/s continuously. In vitro cell experiments confirmed that Cu-Nanobots can significantly promote the oligomerization of dihydrolipoamide acetyltransferase (DLAT), downregulate iron-sulfur cluster proteins such as ferredoxin 1 (FDX1) and lipoic acid synthase (LIAS), and induce cuproptosis in human prostate cancer cells. In addition, Cu-Nanobots can effectively penetrate into the deep area of solid tumors in an animal model with a satisfactory tumor inhibition rate of ∼75.75% under sonication. Overall, these ultrasound-driven cuproptosis-oriented Cu-Nanobots provide optimal insights into effective tumor deep penetration and cuproptosis-based treatment.
- 14 August 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (34) , 48017-48028
Ultrasound-Driven Cu-Nanobots for Tumor Deep Penetration and Induction of Cuproptosis in Prostate Cancer Therapy
Cuproptosis has attracted considerable attention in cancer therapy due to its unique ability to circumvent drug resistance, while the in vivo application is hindered by systemic toxicity, rapid clearance, and limited tumor tissue penetration. Widely recognized for its noninvasive application, ultrasound has emerged as a promising method for enhancing drug tumor penetration. In this study, we developed cuproptosis-oriented Nanobots to achieve deep penetration into prostate tumors under ultrasound irradiation. Asymmetric Cu-Nanobots (∼200 nm) were prepared by ultrasound polymerization using hexachlorocyclotriphosphonitrile (HCCP), 4,4'-sulfonyldiphenol (BPS), and tannic acid (TA) as raw materials, which can efficiently load Cu2+ and trigger Cu2+ release at acidic tumor microenvironments. Under ultrasound stimulation, Cu-Nanobots showed obvious directional motion with a velocity of 19.49 μm/s continuously. In vitro cell experiments confirmed that Cu-Nanobots can significantly promote the oligomerization of dihydrolipoamide acetyltransferase (DLAT), downregulate iron-sulfur cluster proteins such as ferredoxin 1 (FDX1) and lipoic acid synthase (LIAS), and induce cuproptosis in human prostate cancer cells. In addition, Cu-Nanobots can effectively penetrate into the deep area of solid tumors in an animal model with a satisfactory tumor inhibition rate of ∼75.75% under sonication. Overall, these ultrasound-driven cuproptosis-oriented Cu-Nanobots provide optimal insights into effective tumor deep penetration and cuproptosis-based treatment.
- 6 December 2024
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry A
- Vol. 13 (4) , 2780-2788
A peptide-based conductive hydrogel capable of in situ bioelectrocatalytic NADH regeneration for sustained production of 1-propanol
Nicotinamide-adenine dinucleotide (NAD+/NADH) is a coenzyme that acts as a donor and acceptor of electrons in redox reactions within all eukaryotic cells. The reduction of NAD+ produces NADH that subsequently acts as the key electron carrier. However, limited stability of enzymes under operational conditions, unwanted by-products and limited external electron donors result in low efficiency of NADH regeneration to drive the downstream enzymatic reactions. Herein, we modularly designed a peptide hydrogel, which provided an appropriate physiological microenvironment for maintaining the bioactivity of alcohol dehydrogenase. Meanwhile, Bi nanoparticles were in situ synthesized and doped into nanofibers during the peptide self-assembly to afford a conductive hydrogel with enhanced bioelectrocatalytic efficiency. Both linear sweep voltammetry and chronoamperometry data unveiled excellent electrochemical performance of this hydrogel for sustained NADH regeneration at low potential (−0.37 V vs. RHE). Even at a relatively high potential of −0.79 V vs. RHE, the yield of NADH for 10 h was as high as 81%. The regenerated NADH could further drive propionaldehyde alcoholization to produce 1-propanol sustainably with a rate of 1.34 mM h−1 at −0.62 V (vs. RHE). Overall, this peptide-based conductive hydrogel could achieve sustained 1-propanol production by leveraging in situ bioelectrocatalytic NADH regeneration, demonstrating a promising approach for electroenzymatic biofuel and pharmaceutical production.
- 6 December 2024
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry A
- Vol. 13 (4) , 2780-2788
A peptide-based conductive hydrogel capable of in situ bioelectrocatalytic NADH regeneration for sustained production of 1-propanol
Nicotinamide-adenine dinucleotide (NAD+/NADH) is a coenzyme that acts as a donor and acceptor of electrons in redox reactions within all eukaryotic cells. The reduction of NAD+ produces NADH that subsequently acts as the key electron carrier. However, limited stability of enzymes under operational conditions, unwanted by-products and limited external electron donors result in low efficiency of NADH regeneration to drive the downstream enzymatic reactions. Herein, we modularly designed a peptide hydrogel, which provided an appropriate physiological microenvironment for maintaining the bioactivity of alcohol dehydrogenase. Meanwhile, Bi nanoparticles were in situ synthesized and doped into nanofibers during the peptide self-assembly to afford a conductive hydrogel with enhanced bioelectrocatalytic efficiency. Both linear sweep voltammetry and chronoamperometry data unveiled excellent electrochemical performance of this hydrogel for sustained NADH regeneration at low potential (−0.37 V vs. RHE). Even at a relatively high potential of −0.79 V vs. RHE, the yield of NADH for 10 h was as high as 81%. The regenerated NADH could further drive propionaldehyde alcoholization to produce 1-propanol sustainably with a rate of 1.34 mM h−1 at −0.62 V (vs. RHE). Overall, this peptide-based conductive hydrogel could achieve sustained 1-propanol production by leveraging in situ bioelectrocatalytic NADH regeneration, demonstrating a promising approach for electroenzymatic biofuel and pharmaceutical production.
- 17 October 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (43) , 57963-57971
Ultrasound-Responsive Hydrogel Incorporated with TGF-β Mimetic Peptides for Endometrium Recovery to Restore Fertility
Unavoidable damage to the basal layer of the endometrium has a huge negative impact on a woman's reproductive health and menstrual cycle. However, it is difficult for medicine to penetrate a series of biological barriers toward the basal layer in the deeper area of the endometrium. To meet this challenge, we developed an ultrasound-responsive hydrogel incorporated with a transforming growth factor-beta (TGF-β) mimetic peptide to enhance pregnancy outcomes by restoring the function of a wounded endometrium due to its deep-tissue-penetration capability. In vitro studies revealed that the TGF-β-mimetic-peptide-loaded hydrogel could achieve 64.35% of cell migration under ultrasound stimulation even in phosphate-buffered saline of pH 6.0. Upon in situ sonication at the uterus, carboxymethyl chitosan can be released from degraded hydrogel to open tight junctions with reduced interstitial pressure by ultrasound to promote deep penetration. Rat studies revealed that the penetration capability of TGF-β-mimetic-peptide-loaded hydrogel with sonication was 1.6 times higher than that of the control group. Besides the rat uterine model, ex vivo human uterine tissue was also collected and imaged, demonstrating up to ∼700 μm of tissue penetration depth. In addition, compared to control groups, effective uterus recovery without intrauterine stenosis and endometrial cavity fluid was observed from rats with severe uterine injury treated by TGF-β-mimetic-peptide-loaded hydrogel. In addition, fertility restoration in the endometrial injury model was observed after treatment with such an ultrasound-responsive hydrogel incorporated with TGF-β mimetic peptides. Overall, this work provides an effective approach to treating endometrial injury for enhanced pregnancy outcomes.
- 17 October 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (43) , 57963-57971
Ultrasound-Responsive Hydrogel Incorporated with TGF-β Mimetic Peptides for Endometrium Recovery to Restore Fertility
Unavoidable damage to the basal layer of the endometrium has a huge negative impact on a woman's reproductive health and menstrual cycle. However, it is difficult for medicine to penetrate a series of biological barriers toward the basal layer in the deeper area of the endometrium. To meet this challenge, we developed an ultrasound-responsive hydrogel incorporated with a transforming growth factor-beta (TGF-β) mimetic peptide to enhance pregnancy outcomes by restoring the function of a wounded endometrium due to its deep-tissue-penetration capability. In vitro studies revealed that the TGF-β-mimetic-peptide-loaded hydrogel could achieve 64.35% of cell migration under ultrasound stimulation even in phosphate-buffered saline of pH 6.0. Upon in situ sonication at the uterus, carboxymethyl chitosan can be released from degraded hydrogel to open tight junctions with reduced interstitial pressure by ultrasound to promote deep penetration. Rat studies revealed that the penetration capability of TGF-β-mimetic-peptide-loaded hydrogel with sonication was 1.6 times higher than that of the control group. Besides the rat uterine model, ex vivo human uterine tissue was also collected and imaged, demonstrating up to ∼700 μm of tissue penetration depth. In addition, compared to control groups, effective uterus recovery without intrauterine stenosis and endometrial cavity fluid was observed from rats with severe uterine injury treated by TGF-β-mimetic-peptide-loaded hydrogel. In addition, fertility restoration in the endometrial injury model was observed after treatment with such an ultrasound-responsive hydrogel incorporated with TGF-β mimetic peptides. Overall, this work provides an effective approach to treating endometrial injury for enhanced pregnancy outcomes.
- 2 December 2022
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 22 (23) , 9621-9629
Tryptophan-Modulated Nanoscale Metal–Organic Framework for Coordinated Loading of Biomolecules for Cascade Production of Reactive Oxygen and Nitrogen Species
- 2 December 2022
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 22 (23) , 9621-9629
Tryptophan-Modulated Nanoscale Metal–Organic Framework for Coordinated Loading of Biomolecules for Cascade Production of Reactive Oxygen and Nitrogen Species
- 25 May 2022
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 34 (11) , 4937-4945
π–π Interlocking Effect for Designing Biodegradable Nanorods with Controlled Lateral Surface Curvature
- 25 May 2022
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 34 (11) , 4937-4945
π–π Interlocking Effect for Designing Biodegradable Nanorods with Controlled Lateral Surface Curvature
- 31 March 2022
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 144 (16) , 7337-7345
Intracellular Self-Assembly of Peptides to Induce Apoptosis against Drug-Resistant Melanoma
Biosynthesis has been a diverse toolbox to develop bioactive molecules and materials, especially for fabricating modified peptides and their assemblies induced by enzymes. Although desired chemical structures and nanoarchitectures have been achieved, the subsequent interferences of peptide assemblies with organelles and the cellular pathways still remain unsolved important challenges. Herein, we developed a new tripeptide, phenylalanine–phenylalanine–tyrosine (Phe–Phe–Tyr, or FFY), which can be intracellularly oxidized and in situ self-assemble into nanoparticles with excellent interference capability with microtubules and ultimately reverse the drug resistance of melanoma. With the catalysis of tyrosinase, FFY was first oxidized to a melanin-like FFY dimer (mFFY) with a diquinone structure for further self-assembling into mFFY assemblies, which could inhibit the self-polymerization of tubulin to induce severe G2/M arrest (13.9% higher than control). Afterward, mitochondrial dysfunction was also induced for overproduction of cleaved caspase 3 (3.1 times higher than control) and cleaved PARP (6.3 times higher), achieving a high level of resistant reversing without chemotherapeutic drugs. In vivo studies showed that the resistant melanoma tumor volumes were reduced by 87.4% compared to control groups after FFY treatment by peritumoral injections. Overall, this tyrosinase-induced tripeptide assembly has been demonstrated with effective intrinsic apoptosis against drug-resistant melanoma, providing a new insight into utilizing biomolecules to interfere with organelles to activate certain apoptosis pathways for treatment of drug-resistant cancer.
- 31 March 2022
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 144 (16) , 7337-7345
Intracellular Self-Assembly of Peptides to Induce Apoptosis against Drug-Resistant Melanoma
Biosynthesis has been a diverse toolbox to develop bioactive molecules and materials, especially for fabricating modified peptides and their assemblies induced by enzymes. Although desired chemical structures and nanoarchitectures have been achieved, the subsequent interferences of peptide assemblies with organelles and the cellular pathways still remain unsolved important challenges. Herein, we developed a new tripeptide, phenylalanine–phenylalanine–tyrosine (Phe–Phe–Tyr, or FFY), which can be intracellularly oxidized and in situ self-assemble into nanoparticles with excellent interference capability with microtubules and ultimately reverse the drug resistance of melanoma. With the catalysis of tyrosinase, FFY was first oxidized to a melanin-like FFY dimer (mFFY) with a diquinone structure for further self-assembling into mFFY assemblies, which could inhibit the self-polymerization of tubulin to induce severe G2/M arrest (13.9% higher than control). Afterward, mitochondrial dysfunction was also induced for overproduction of cleaved caspase 3 (3.1 times higher than control) and cleaved PARP (6.3 times higher), achieving a high level of resistant reversing without chemotherapeutic drugs. In vivo studies showed that the resistant melanoma tumor volumes were reduced by 87.4% compared to control groups after FFY treatment by peritumoral injections. Overall, this tyrosinase-induced tripeptide assembly has been demonstrated with effective intrinsic apoptosis against drug-resistant melanoma, providing a new insight into utilizing biomolecules to interfere with organelles to activate certain apoptosis pathways for treatment of drug-resistant cancer.
- 1 November 2021
- Published by Elsevier in Biomaterials
- Vol. 278, 121168
Mitochondrial-targeting nanoprodrugs to mutually reinforce metabolic inhibition and autophagy for combating resistant cancer
- 1 November 2021
- Published by Elsevier in Biomaterials
- Vol. 278, 121168
Mitochondrial-targeting nanoprodrugs to mutually reinforce metabolic inhibition and autophagy for combating resistant cancer
- 12 October 2021
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 33 (20) , 7972-7985
Polymersome Wound Dressing Spray Capable of Bacterial Inhibition and H2S Generation for Complete Diabetic Wound Healing
- 12 October 2021
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 33 (20) , 7972-7985
Polymersome Wound Dressing Spray Capable of Bacterial Inhibition and H2S Generation for Complete Diabetic Wound Healing